Bangi PP&E per Employee
The PP&E per Employee of Bangi (BNGI) as of Aug 4, 2026 is 150.00 USD.
Get this data via API
Financial Data API
PP&E per Employee
150.00USD
Last updated:
PP&E per Employee of Bangi is 2026 150.00 USD. PP&E per Employee of Bangi was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Bangi Stock analysis
What does Bangi do? Bangi Inc is a versatile company based in the USA. It was founded in 2010 with the aim of investing in emerging markets in Africa and elsewhere, particularly in areas such as agriculture and technology.
The history of Bangi Inc is closely linked to that of its founder, entrepreneur and philanthropist Sybil Ackerman-Munson. She was born and raised in Zimbabwe and has maintained a strong connection to her continent throughout her life. After studying in the USA, she founded a company called Zimbabwe Economic Development Initiatives (ZEDI) in 2007, which focused on microcredit and other development projects.
Three years later, Ackerman-Munson decided to expand her vision and founded Bangi Inc. The company began by supporting farmers in Zimbabwe who wanted to enter the cultivation of hemp for medical purposes. Over time, however, Bangi Inc grew into a multi-business company with multiple areas and products.
The business model of Bangi Inc is to invest in emerging markets and create business opportunities there. The company's focus areas include agriculture, healthcare, technology, and intellectual property. In all areas, Bangi Inc strives to promote sustainable and positive change.
In agriculture, Bangi Inc focuses on the cultivation of hemp for medical purposes. The company works with farmers and communities to build the necessary infrastructure and impart the knowledge and skills required for successful hemp cultivation. Bangi Inc also utilizes advanced technology to optimize the cultivation process and monitor the harvest.
In healthcare, Bangi Inc is interested in developing and promoting innovative solutions for disease treatment. The company invests in research and development and collaborates with other companies and institutions to create products and services that improve people's lives.
In the technology industry, Bangi Inc focuses on acquiring and developing intellectual property. The company invests in patents and technologies, which it then licenses or further develops to create new and innovative products and services.
The company is also involved in the entertainment industry and has introduced the brand "BANGI" for music, films, and other entertainment products. The company has also entered into a joint venture with the production company "The Multimillionaires" to undertake additional music and film projects.
In addition to its business areas, Bangi Inc offers a variety of products, including CBD oils, hemp flowers, hemp powder, and hemp tinctures. The company also has its own product line called "Synergee," which consists of hemp products for medical purposes.
Overall, Bangi Inc is a company focused on creating positive and sustainable change, particularly in emerging markets like Africa. With a wide range of products, services, and investment opportunities, Bangi Inc is in a unique position to promote positive change in the world. Bangi is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Bangi stock
PP&E per Employee of Bangi is 150.00 USD in 2026.
On Eulerpool you can find the complete historical development of PP&E per Employee Bangi since 2006 – with annual values, charts, and detailed analysis.
PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.
PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Bangi historically and in real time.
Access this data via the Eulerpool API
Workforce — Bangi
All Key Metrics — Bangi
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth